59 related articles for article (PubMed ID: 24353023)
1. Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects.
Zannikos PN; Smit JW; Stahlberg HJ; Wenge B; Hillewaert VM; Etropolski MS
J Opioid Manag; 2013; 9(4):291-300. PubMed ID: 24353023
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist.
Toyama K; Furuie H; Kuroda K; Ishizuka H
Drugs R D; 2017 Sep; 17(3):363-370. PubMed ID: 28516342
[TBL] [Abstract][Full Text] [Related]
3. Effect of Food, Crushing of Tablets, and Antacid Coadministration on Maribavir Pharmacokinetics in Healthy Adult Participants: Results From 2 Phase 1, Open-Label, Randomized, Crossover Studies.
Sun K; Ilic K; Xu P; Ye R; Wu J; Song IH
Clin Pharmacol Drug Dev; 2024 Jun; 13(6):644-654. PubMed ID: 38708555
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.
Chung M; Vashi V; Puente J; Sweeney M; Meredith P
Br J Clin Pharmacol; 1999 Nov; 48(5):678-87. PubMed ID: 10594469
[TBL] [Abstract][Full Text] [Related]
5. Safety, Tolerability, and Pharmacokinetics of Valemetostat Tablets and the Effect of Food on Valemetostat Pharmacokinetics in Healthy Subjects: Two Phase 1 Studies.
Tachibana M; Matsuki S; Toyama K; Maekawa Y; Fukae M; Shimizu T; Tsutsumi J; Shinohara S; Ishizuka H
Clin Pharmacol Drug Dev; 2024 Jan; 13(1):77-86. PubMed ID: 37565616
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Food Effect Between a 100-mg Sustained-Release Tablet and a 50-mg Immediate-Release Tablet of Vildagliptin in Healthy Subjects.
Yoo H; Shin W; Lee B; Park J; Lee Y; Kim A
Clin Pharmacol Drug Dev; 2024 Feb; 13(2):122-127. PubMed ID: 37548105
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects.
Cardot JM; Chaumont C; Dubray C; Costantini D; Aiache JM
Br J Clin Pharmacol; 2004 Oct; 58(4):345-51. PubMed ID: 15373926
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus.
Hawi A; Alcorn H; Berg J; Hines C; Hait H; Sciascia T
BMC Nephrol; 2015 Apr; 16():47. PubMed ID: 25885112
[TBL] [Abstract][Full Text] [Related]
9. Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers.
Farr SJ; Robinson CY; Rubino CM
Clin Pharmacol; 2015; 7():1-9. PubMed ID: 25653563
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study.
Samara E; Winkle P; Pardo P; Henney HR; Way SL; Brown E; Lee A; Blight AR
J Clin Pharmacol; 2014 Jan; 54(1):53-60. PubMed ID: 24150835
[TBL] [Abstract][Full Text] [Related]
11. Bioequivalence of 240 mg Apalutamide Tablets and Preparation in Aqueous Food Vehicles for Alternative Administration.
Yu A; Van Uffel M; Jiao JJ; Rosales R; Erba M; Haddish-Berhane N
Clin Pharmacol Drug Dev; 2024 Apr; 13(4):432-439. PubMed ID: 37987029
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic modeling of levodropropizine: extended application to comparative analysis between commercial formulations and exploration of pharmacokinetic effects of diet.
Jeong SH; Jang JH; Lee YB
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4403-4418. PubMed ID: 38103059
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of the gastric residence time of caffeine after administration in fed state: Comparison of effervescent granules with an extended release tablet.
Foja C; Senekowitsch S; Winter F; Grimm M; Rosenbaum C; Koziolek M; Feldmüller M; Kromrey ML; Scheuch E; Tzvetkov MV; Weitschies W; Schick P
Eur J Pharm Biopharm; 2024 Jun; 199():114313. PubMed ID: 38718842
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects.
Khwarg J; Chung WK; Lee S; Yang E; Ryu C; Lee DY; Lee MJ; Jang IJ; Yu KS; Lee S
Clin Pharmacol Drug Dev; 2024 Feb; 13(2):128-133. PubMed ID: 38156730
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of pravastatin in Mexicans: An open-label study in healthy adult volunteers.
Escobar Y; Venturelli CR; Hoyo-Vadillo C
Curr Ther Res Clin Exp; 2005 May; 66(3):238-46. PubMed ID: 24672127
[TBL] [Abstract][Full Text] [Related]
16. Venetoclax Clinical Pharmacokinetics After Administration of Crushed, Ground or Whole Tablets.
Alaei S; Wang Y; Liu Y; Schiele J; Deng R; Shiller D; Marroum P; Menon R; Salem AH
Clin Ther; 2024 May; ():. PubMed ID: 38782609
[TBL] [Abstract][Full Text] [Related]
17. Tapentadol dependence through intravenous injection ('shooting') of crushed tablets associated with cutaneous pseudoallergic reactions.
Avula VCR; Vullanki SS; Munivenkatappa S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38114296
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old.
Khalil F; Choi SL; Watson E; Tzschentke TM; Lefeber C; Eerdekens M; Freijer J
J Pain Res; 2020; 13():3107-3123. PubMed ID: 33262645
[TBL] [Abstract][Full Text] [Related]
19. Tablets, toddlers and tantrums: The immediate effects of tablet device play.
Munzer TG; Miller AL; Wang Y; Kaciroti N; Radesky JS
Acta Paediatr; 2021 Jan; 110(1):255-256. PubMed ID: 32735726
[No Abstract] [Full Text] [Related]
20. Population Pharmacokinetic Modeling of Tapentadol Extended Release (ER) in Healthy Subjects and Patients with Moderate or Severe Chronic Pain.
Huntjens DR; Liefaard LC; Nandy P; Drenth HJ; Vermeulen A
Clin Drug Investig; 2016 Mar; 36(3):213-23. PubMed ID: 26798023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
